Sort
21,281 grants matching “influenza”
Future of influenza vaccine strategies given interference and choice
$400,953Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · GM
MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION
$400,862Lukas K Tamm · University Of Virginia · R37 · FY2008 · AI
Study of hemagglutinin membrane fusion domain
$400,847Ad Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Foundation Immunogens for Influenza Vaccines
$400,826Eric A Weaver · Mayo Clinic Rochester · R01 · FY2014 · AI
Broad-Range VLP Vaccine Against H5N1 Influenza
$400,757Peter M. Pushko · Medigen, Inc. · R01 · FY2015 · AI
Clinical Studies of Vaccines for Pandemic Influenza
$400,655Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
COVID Global Mix - Global Mix / Investigation of COVID-19 Disease Parameters for Transmission Models in Low-Resource Settings
$400,628Saad B. Omer · Ut Southwestern Medical Center · R01 · FY2025 · AI
Unfolded protein response in Influenza virus infection and inflammation
$400,607Vikas Anathy · University Of Vermont & St Agric College · R01 · FY2019 · HL
CD137 signals in DV during Ag-priming induces tolerance
$400,606Robert S Mittler · Emory University · R01 · FY2007 · AI
Modulation of Viral Antigen Presentation in the Lung
$400,545Anna Karolina Palucka · Jackson Laboratory · U19 · FY2020 · AI
Stat 1 modification for antiviral defense
$400,534Michael Jay Holtzman · Washington University · U54 · FY2010 · AI
Function of NALT in nasal immunization to heterotypic strains of influenza
$400,500Troy D Randall · Trudeau Institute, Inc. · R01 · FY2007 · AI
NAD and CD38: modulators of inflammation and immunity
$400,500Frances E. Lund · Trudeau Institute, Inc. · R01 · FY2007 · AI
Novel Inhibitors of Viral Replication
$400,455Michael G Roth · Ut Southwestern Medical Center · R01 · FY2011 · AI
Using Chemical Biology to Interfere with the Influenza Virus Life Cycle
$400,455Michael G Roth · Ut Southwestern Medical Center · R01 · FY2011 · AI
Task C06: Lung Microphysiological Systems as Models of Infectious Diseases for BSL-3 Pathogens
$400,432David Beasley · University Of Texas Med Br Galveston · N01 · FY2020 · AI
Functional and developmental T cell subsets
$400,332Jonathan Ashwell · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A New Antibacterial Drug Target: Analyzing Inhibitor Binding to a Bacterial Metal
$400,175Daniel Paul Becker · Loyola University Of Chicago · R15 · FY2010 · AI
Innate Regulation of CD8+ T Cell Effector Activites
$400,135Richard I Enelow · University Of Virginia · U19 · FY2011 · AI
Evaluation of IFNy - Producin Effector Cells in Infectious and Autoimmune Disease
$400,101Frances E. Lund · Emory University · P01 · FY2013 · AI
Protective Cell-Mediated Immunity Against Lethal H5N1 Influenza A Viruses
$400,072Peter C Doherty · St. Jude Children'S Research Hospital · R01 · FY2009 · AI
Sustaining Surveillance Networks and Response to Seasonal and Pandemic Influenza
$400,066Jean-Michel Heraud · Pasteur Institute From Madagascar · U51 · FY2013 · IP
Human monoclonal antibodies for prophylaxis and therapy against the new coronavirus
$400,050Michel C Nussenzweig · Rockefeller University · P01 · FY2020 · AI
Identifying novel regulatory pathways underlying T helper 1 cell immune responses
$400,026Kenneth Joseph Oestreich · Virginia Polytechnic Inst And St Univ · R01 · FY2018 · AI
Surveillance and Response to Avian /Pandemic Influenza
$400,000Katya Gamazina · Path · U51 · FY2007 · CI